Evidence map›Paper›PMID 40678461›Full record

ArticleMethodsX2025

Integrated deep learning for cardiovascular risk assessment and diagnosis: An evolutionary mating algorithm-enhanced CNN-LSTM.

Ahmed Mohammed Ahmed Alsarori, Mohd Herwan Sulaiman

Abstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ahmed Mohammed Ahmed AlsaroriFaculty of Electrical & Electronics Engineering Technology, Universiti Malaysia Pahang Al-Sultan Abdullah (UMPSA), 26600 Pekan Pahang, Malaysia.
Mohd Herwan SulaimanFaculty of Electrical & Electronics Engineering Technology, Universiti Malaysia Pahang Al-Sultan Abdullah (UMPSA), 26600 Pekan Pahang, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases (CVD) remain the leading cause of mortality worldwide, emphasizing the urgent need for accurate and efficient predictive models. This study proposes a dual-output deep learning model based on a hybrid Convolutional Neural Network-Long Short-Term Memory (CNN-LSTM) model, optimized using the Evolutionary Mating Algorithm (EMA). The model predicts both a continuous risk score and a binary diagnostic outcome, supporting both quantitative assessment and early clinical decision-making. EMA was applied for hyperparameter optimization, demonstrating improved convergence and generalization over conventional methods. Performance was benchmarked against CNN-LSTM models optimized using Particle Swarm Optimization (PSO) and Barnacle Mating Optimization (BMO). The EMA-based model achieved superior results, with a Mean Absolute Error (MAE) of 0.018, Mean Squared Error (MSE) of 0.0006, Root Mean Squared Error (RMSE) of 0.024, and a coefficient of determination (R²) of 0.98 for risk prediction. For the diagnostic task, the model attained 70 % accuracy and 80 % precision. These findings validate EMA's effectiveness in tuning dual-output deep learning models and highlight its potential in enhancing cardiovascular risk stratification and early diagnosis in clinical settings.•Dual-output CNN-LSTM model optimized using EMA.•Continuous risk scores and binary diagnostic classification predictions.•EMA outperformed PSO and BMO in predictive accuracy and model robustness.

Indexed as

Cardiovascular diseaseConvolutional neural networkDeep learningDual Output CNN-LSTM-EMAEvolutionary mating algorithmHybrid modelLong Short-Term MemoryMachine learning

Identifiers

PMID40678461
PMCPMC12268569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.